These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9800292)

  • 1. Complement activation during plasma production depends on the apheresis technique.
    Sonntag J; Emeis M; Vornwald A; Strauss E; Maier RF
    Transfus Med; 1998 Sep; 8(3):205-8. PubMed ID: 9800292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxins in fresh-frozen plasma.
    Sonntag J; Stiller B; Walka MM; Maier RF
    Transfusion; 1997 Aug; 37(8):798-803. PubMed ID: 9280323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of complement activation during membrane-based plasmapheresis procedures.
    Burnouf T; Eber M; Kientz D; Cazenave JP; Burkhardt T
    J Clin Apher; 2004; 19(3):142-7. PubMed ID: 15493055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of C3a and C5a in hemapheresis procedures].
    Schooneman F; Marchand M; Vigneron C; Streiff F
    Ann Med Interne (Paris); 1990; 141(7):597-9. PubMed ID: 2085237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylatoxin and terminal complement complexes in red cell salvage.
    Bengtsson A; Lisander B
    Acta Anaesthesiol Scand; 1990 Jul; 34(5):339-41. PubMed ID: 2389647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement system activation during orthotopic liver transplantation in man. Indications of peroperative complement system activation in the gut.
    Rønholm E; Tomasdottir H; Runeborg J; Bengtsson A; Bengtson JP; Stenqvist O; Friman S
    Transplantation; 1994 Jun; 57(11):1594-7. PubMed ID: 8009593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
    Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
    Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation.
    Graulich J; Sonntag J; Marcinkowski M; Bauer K; Kössel H; Bührer C; Obladen M; Versmold HT
    Mediators Inflamm; 2002 Apr; 11(2):69-73. PubMed ID: 12061426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of anaphylatoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters.
    Geiger TL; Perrotta PL; Davenport R; Baril L; Snyder EL
    Transfusion; 1997; 37(11-12):1156-62. PubMed ID: 9426639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in relation to development of preeclampsia.
    Haeger M; Unander M; Bengtsson A
    Obstet Gynecol; 1991 Jul; 78(1):46-9. PubMed ID: 2047067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of activated complement from shed blood: comparison of high- and low-dilutional haemofiltration.
    Arnestad JP; Hyllner M; Bengtson JP; Tylman M; Mollnes TE; Bengtsson A
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):811-5. PubMed ID: 9698958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation during liver transplantation.
    Tomasdottir H; Henriksson BA; Bengtson JP; Bengtsson A; Stenqvist O; Persson H
    Transplantation; 1993 Apr; 55(4):799-802. PubMed ID: 8475554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation in neonatal disease.
    Zilow EP
    Eur J Pediatr; 1993 May; 152(5):459-60. PubMed ID: 8319722
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of the complement system by different autologous transfusion devices: an in vitro study.
    Tylman M; Bengtson JP; Bengtsson A
    Transfusion; 2003 Mar; 43(3):395-9. PubMed ID: 12675727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryofiltration apheresis in the United States.
    Siami GA; Siami FS
    Ther Apher; 1998 Aug; 2(3):228-35. PubMed ID: 10227775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis.
    Gloor B; Stahel PF; Müller CA; Schmidt OI; Büchler MW; Uhl W
    Scand J Gastroenterol; 2003 Oct; 38(10):1078-82. PubMed ID: 14621284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylatoxins C3a and C5a adsorption on acrylonitrile membrane of hollow-fiber and plate dialyzer--an in vivo study.
    Kandus A; Ponikvar R; Drinovec J; Kladnik S; Ivanovich P
    Int J Artif Organs; 1990 Mar; 13(3):176-80. PubMed ID: 2347666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between complement system's activation factors and anti-angiogenesis factors in plasma of patients with early/late-onset severe preeclampsia.
    He Y; Xu B; Song D; Yu F; Chen Q; Zhao M
    Hypertens Pregnancy; 2016 Nov; 35(4):499-509. PubMed ID: 27315511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic treatment and complement activation.
    Agostoni A; Gardinali M; Frangi D; Cugno M; Cafaro C; Conciato L; Sponzilli C; Salmoirago E
    Ann Ital Med Int; 1994; 9(3):178-9. PubMed ID: 7946896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activation of complement system by lactic acidosis in newborn and adults.
    Hecke F; Hoehn T; Strauss E; Obladen M; Sonntag J
    Mediators Inflamm; 2001 Feb; 10(1):27-31. PubMed ID: 11324901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.